GRMLNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as GRMLW
Greenland Mines Ltd
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 17, 2026
$5.61−0.39 (-6.50%)
Close on Oct 19, 2026
- Market cap
- $709.78M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$24.42 (−81.32%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Split
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Jun 30, 2026
Valuation
- Market cap
- $709.78M
- P/E ratio
- –
- Price to sales
- –
- Price to book
- 12.26
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Net income
- -$21.77M
- EPS, diluted
- -$0.25
- Book value per share
- $0.46
- Diluted shares
- 127M
Five years at a glance
Fiscal years 2021 to 2025 and trailing twelve months, USD
Operating income
-$18.67M
Net income
-$21.77M
EPS, diluted
-$0.25
Reported periodTrailing twelve months